Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery

NCT03028623
completed

Proportion of Hysterectomy After Female Sterilization

NCT02532361
unknownnot_applicable

Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section

NCT02377128

Clinical Trials (3)

Showing 3 of 3 trials
NCT03028623Not Applicable

Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery

Completed
NCT02532361

Proportion of Hysterectomy After Female Sterilization

Completed
NCT02377128Not Applicable

Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3